Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Crispr Therapeutics Ag (CRSP)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
EcoR1 Capital

Oleg Nodelman

500,000 $22,175 1.99%
2. 337,731 $14,978 -12% 1.41%
3.
Casdin Capital

Eli Casdin

220,000 $9,757 1.18%
4.
Valiant Capital

Christopher R. Hansen

271,700 $12,050 1.06%
5.
VenBio Select Advisor

Kurt Von Emster

147,368 $6,536 0.3%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$22.75 527,472 Large Shareholder 5,632,802 2018-01-05 Filing
$22.75 65,934 Director 1,887,202 2018-01-05 Filing
$14.00 56,000 Director 2,601,814 2016-10-24 Filing
$14.00 400 Officer 505,617 2016-10-24 Filing
$14.00 4,583 Large Shareholder 185,987 2016-10-24 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$62.00 1,684 Director 0 2018-07-05 Filing
$62.00 5,816 Director 0 2018-07-03 Filing
$12.51 920 Director 18,316 2018-06-05 Filing
$70.28 10,400 Officer, Director 148,560 2018-06-01 Filing
$67.28 4,600 Officer, Director 158,960 2018-06-01 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 3,608,874 $160,053,562 54.43%
2. 1,237,202 $54,858 32.61%
3. 2,090,678 $92,722 4%
4. 444,708 $19,723 3.58%
5. 1,453,590 $64,467 1.94%